<DOC>
	<DOCNO>NCT00306722</DOCNO>
	<brief_summary>Very often patient receive medication diagnostic , therapeutic , surgical procedure help relax , keep calm , relieve pain . This call procedural sedation . During procedural ( mild-to-moderate ) sedation , patient first give pain-relief medication ( analgesic ) medication help him/her relax keep him/her calm ( sedative ) . Propofol drug commonly use sedation release immediately blood stream cause fast sedation . AQUAVAN ( fospropofol disodium ) make slow release version propofol long duration effect .</brief_summary>
	<brief_title>An Effectiveness Safety Study AQUAVAN® Injection ( Fospropofol Disodium ) Sedation During Flexible Bronchoscopy</brief_title>
	<detailed_description>This phase 3 , randomize , double-blind , dose-controlled study design evaluate efficacy safety AQUAVAN 6.5 mg/kg compare minimally effective dose AQUAVAN 2.0 mg/kg , follow pretreatment analgesic , fentanyl patient undergo flexible bronchoscopy . Following completion preprocedure assessment , patient randomly assign 1 2 treatment group 2:3 ( AQUAVAN initial dose 1 [ 2.0 mg/kg ] : AQUAVAN initial dose 2 [ 6.5 mg/kg ] allocation ratio day schedule procedure . Randomization stratify site . A person skilled airway management ( respiratory therapist , study nurse , clinician ) authorize facility colonoscopy perform must immediately available conduct study . All patient place supplemental oxygen via nasal cannula ( 4 L/min ) , ECG monitor , pulse oximeter , blood pressure monitor attach prior administration study medication . All patient receive analgesic pretreatment ( fentanyl citrate injection pain ; lidocaine topical anesthetic follow administration study medication . Assessments make evaluate patient level sedation , clinical benefit sedation , adverse event . Blood sample collect PK analysis .</detailed_description>
	<mesh_term>Fospropofol</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<criteria>1 . Patient must able understand , either orally write , able consent complete require assessment procedures 2 . Patient provide signed/dated Informed Consent Health Insurance Portability Accountability Act 1996 ( HIPAA ) authorization receive full explanation extent nature study . 3 . Patient must least 18 year age time screen . 4 . If female , patient must surgically sterile , postmenopausal , pregnant lactating must use acceptable method birth control least 1 month prior dose , negative urine pregnancy test result screen predose . 5 . Patient meet American Society Anesthesiologists ( ASA ) Physical Classification System status P1 P4 . 1 . Patient history allergic reaction hypersensitivity anesthetic agent opioid . 2 . Patient meet nil per o ( NPO ) status per ASA guideline institution 's guideline . 3 . Patient Mallampati Classification Score 4 ; OR Mallampati Classification Score 3 AND thyromental distance ≤4 cm , reason difficult airway , opinion Investigator . 4 . Patient abnormal , clinically significant 3lead ECG find predosing period Day 0 . 5 . Patient participate investigational drug study within 1 month prior study start . 6 . Patient unwilling adhere pre postprocedural instruction . 7 . Patient use fentanyl citrate injection ( fentanyl ) contraindicate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Bronchoscopy</keyword>
	<keyword>Sedation</keyword>
	<keyword>AQUAVAN</keyword>
	<keyword>fospropofol disodium</keyword>
	<keyword>Flexible bronchoscopy</keyword>
</DOC>